Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126006091 | 12600609 | 1 | I | 2010 | 20160719 | 20160727 | 20160727 | EXP | US-ASTRAZENECA-2016SE79254 | ASTRAZENECA | 82.00 | YR | F | Y | 90.70000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126006091 | 12600609 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | 2557 | MG | 20541 | 1 | MG | TABLET | QD | |||||
126006091 | 12600609 | 2 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 90 UG, TWO PUFFS, TWO TIMES A DAY | N | U | 0 | INHALATION POWDER | |||||||
126006091 | 12600609 | 3 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | 0 | 2.5 | MG | BID | ||||||||
126006091 | 12600609 | 4 | C | COREG | CARVEDILOL | 1 | Oral | 0 | 6.25 | MG | BID | ||||||||
126006091 | 12600609 | 5 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 0 | 10 | MEQ | BID | ||||||||
126006091 | 12600609 | 6 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
126006091 | 12600609 | 7 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
126006091 | 12600609 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | QD | ||||||||
126006091 | 12600609 | 9 | C | MIRAPEX ER | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | 0 | 2.5 | MG | QD | ||||||||
126006091 | 12600609 | 10 | C | THERACRAN | 2 | Oral | TWICE DAILY | 0 | |||||||||||
126006091 | 12600609 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | 1000 | IU | QD | ||||||||
126006091 | 12600609 | 12 | C | EYE CAPS-PRESERVISION AREDS NO. 2 | 2 | Oral | 1 TAB TWICE DAILY | 0 | |||||||||||
126006091 | 12600609 | 13 | C | SANTURA TRIPODIUM CHLORIDE | 2 | 0 | 20 | MG | QD | ||||||||||
126006091 | 12600609 | 14 | C | LEVADOPA | 2 | Oral | 25/100 GIVE 1??? TABS THREE TIMES DAILY | 0 | |||||||||||
126006091 | 12600609 | 15 | C | REMERON | MIRTAZAPINE | 1 | Oral | 0 | 15 | MG | QD | ||||||||
126006091 | 12600609 | 16 | C | REMERON | MIRTAZAPINE | 1 | Oral | 0 | 15 | MG | QD | ||||||||
126006091 | 12600609 | 17 | C | TESSALON BENZONONATE | 2 | Oral | 100 MG, THREE TIMES A DAY AND ADDITIONAL 3 TIMES PER DAY AS NEEDED | 0 | |||||||||||
126006091 | 12600609 | 18 | C | CHLORATRIMITON | 2 | Oral | AS NEEDED FOR DECADES | 0 | |||||||||||
126006091 | 12600609 | 19 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | AS NEEDED | 0 | ||||||||||
126006091 | 12600609 | 20 | C | DORZOLMIDE-TIMOLOL | 2 | Ophthalmic | EYE DROPS 1 DROP IN RIGHT EYE TWICE DAILY | 0 | |||||||||||
126006091 | 12600609 | 21 | C | LATANOPROST. | LATANOPROST | 1 | Ophthalmic | 0.005% 1 DROP IN RIGHT EYE NIGHTLY | 0 | 1 | GTT | EYE DROPS | QD | ||||||
126006091 | 12600609 | 22 | C | ALPHAGAN P | BRIMONIDINE TARTRATE | 1 | Ophthalmic | 1 DROP IN RIGHT EYE DAILY | 0 | EYE DROPS | |||||||||
126006091 | 12600609 | 23 | C | XELANTAN | 2 | Ophthalmic | IN RIGHT EYE | 0 | EYE DROPS | ||||||||||
126006091 | 12600609 | 24 | C | TIMOLOL. | TIMOLOL | 1 | Ophthalmic | IN LEFT EYE | 0 | EYE DROPS | |||||||||
126006091 | 12600609 | 25 | C | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 8 INTERNATIONAL UNITS SUBQ TWICE DAILY WITH BREAKFAST AND LUNCH | 0 | ||||||||||
126006091 | 12600609 | 26 | C | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 10 INTERNATIONAL UNITS SUBQ WITH DINNER | 0 | ||||||||||
126006091 | 12600609 | 27 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 34 INTERNATIONAL UNITS SUBQ AT 11:00 PM NIGHTLY | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126006091 | 12600609 | 1 | Neoplasm malignant |
126006091 | 12600609 | 2 | Asthma |
126006091 | 12600609 | 3 | Cardiac failure congestive |
126006091 | 12600609 | 4 | Cardiac disorder |
126006091 | 12600609 | 6 | Stent placement |
126006091 | 12600609 | 7 | Hot flush |
126006091 | 12600609 | 8 | Blood cholesterol abnormal |
126006091 | 12600609 | 9 | Parkinson's disease |
126006091 | 12600609 | 10 | Cystitis |
126006091 | 12600609 | 12 | Vitamin supplementation |
126006091 | 12600609 | 13 | Incontinence |
126006091 | 12600609 | 14 | Parkinson's disease |
126006091 | 12600609 | 15 | Antidepressant therapy |
126006091 | 12600609 | 16 | Insomnia |
126006091 | 12600609 | 17 | Cough |
126006091 | 12600609 | 18 | Antiallergic therapy |
126006091 | 12600609 | 20 | Eye disorder |
126006091 | 12600609 | 21 | Eye disorder |
126006091 | 12600609 | 22 | Eye disorder |
126006091 | 12600609 | 23 | Eye disorder |
126006091 | 12600609 | 24 | Eye disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126006091 | 12600609 | OT |
126006091 | 12600609 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126006091 | 12600609 | Asthma | |
126006091 | 12600609 | Bladder cancer | |
126006091 | 12600609 | Breast cancer | |
126006091 | 12600609 | Diabetes mellitus | |
126006091 | 12600609 | Glaucoma | |
126006091 | 12600609 | Hypersensitivity | |
126006091 | 12600609 | Intestinal obstruction | |
126006091 | 12600609 | Intraocular pressure increased | |
126006091 | 12600609 | Large intestine perforation | |
126006091 | 12600609 | Malaise | |
126006091 | 12600609 | Parkinson's disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126006091 | 12600609 | 1 | 2009 | 0 | ||
126006091 | 12600609 | 2 | 201604 | 201607 | 0 | |
126006091 | 12600609 | 3 | 201404 | 0 | ||
126006091 | 12600609 | 4 | 201404 | 0 | ||
126006091 | 12600609 | 5 | 201404 | 0 | ||
126006091 | 12600609 | 6 | 201404 | 0 | ||
126006091 | 12600609 | 7 | 2010 | 0 | ||
126006091 | 12600609 | 12 | 2013 | 0 | ||
126006091 | 12600609 | 13 | 2006 | 0 | ||
126006091 | 12600609 | 14 | 2014 | 0 | ||
126006091 | 12600609 | 15 | 2015 | 0 | ||
126006091 | 12600609 | 16 | 2015 | 0 | ||
126006091 | 12600609 | 17 | 2015 | 0 | ||
126006091 | 12600609 | 20 | 2013 | 0 | ||
126006091 | 12600609 | 21 | 2013 | 0 | ||
126006091 | 12600609 | 22 | 201605 | 0 | ||
126006091 | 12600609 | 23 | 201605 | 0 | ||
126006091 | 12600609 | 24 | 201605 | 0 |